In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9
暂无分享,去创建一个
Roberto Todeschini | Viviana Consonni | Francesca Grisoni | Serena Nembri | R. Todeschini | V. Consonni | F. Grisoni | Serena Nembri
[1] S. Hirono,et al. Simple Method of Calculating Octanol/Water Partition Coefficient. , 1992 .
[2] Roberto Todeschini,et al. Reshaped Sequential Replacement for variable selection in QSPR: comparison with other reference methods , 2014 .
[3] Roberto Todeschini,et al. Investigating the mechanisms of bioconcentration through QSAR classification trees. , 2016, Environment international.
[4] Roberto Todeschini,et al. N3 and BNN: Two New Similarity Based Classification Methods in Comparison with Other Classifiers , 2015, J. Chem. Inf. Model..
[5] A. Karlin,et al. Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. , 1994, Biochemistry.
[6] C. Hansch,et al. Quantitative structure-activity relationships of cytochrome P-450. , 1993, Drug metabolism reviews.
[7] Ruili Huang,et al. Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity across Chemical Libraries , 2009, Nature Biotechnology.
[8] Sean Ekins,et al. KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4 , 2004, Drug Metabolism and Disposition.
[9] A. Munro,et al. What makes a P450 tick? , 2013, Trends in biochemical sciences.
[10] G. Caldwell,et al. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. , 2001, Current topics in medicinal chemistry.
[11] M. Schwab,et al. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.
[12] F. Guengerich,et al. Role of cytochrome P450 enzymes in drug-drug interactions. , 1997, Advances in pharmacology.
[13] Pengyu Y. Ren,et al. Calculation of protein–ligand binding free energy by using a polarizable potential , 2008, Proceedings of the National Academy of Sciences.
[14] M. Clifford,et al. Quantitative structure activity relationship for the effect of benzoic acids, cinnamic acids and benzaldehydes on Listeria monocytogenes. , 1996, The Journal of applied bacteriology.
[15] Yongjun Wang,et al. Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction , 2008, J. Comput. Aided Mol. Des..
[16] Roberto Todeschini,et al. Comparison of Different Approaches to Define the Applicability Domain of QSAR Models , 2012, Molecules.
[17] J. Bridges,et al. The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristics. , 1978, Biochemical pharmacology.
[18] P. Watkins. Role of Cytochromes P45O in Drug Metabolism and Hepatotoxicity , 1990, Seminars in liver disease.
[19] Michael C. Brown. An Adverse Interaction between Warfarin and 5-Fluorouracil: A Case Report and Review of the Literature , 1999, Chemotherapy.
[20] Mark A. Murcko,et al. Virtual screening : an overview , 1998 .
[21] D. Butina,et al. Performance of Kier-Hall E-state descriptors in quantitative structure activity relationship (QSAR) studies of multifunctional molecules. , 2004, Molecules.
[22] Ola Spjuth,et al. WhichCyp: prediction of cytochromes P450 inhibition , 2013, Bioinform..
[23] G. McLachlan. Discriminant Analysis and Statistical Pattern Recognition , 1992 .
[24] Yu Zong Chen,et al. Prediction of Cytochrome P450 3A4, 2D6, and 2C9 Inhibitors and Substrates by Using Support Vector Machines , 2005, J. Chem. Inf. Model..
[25] Leo Breiman,et al. Classification and Regression Trees , 1984 .
[26] BioChem Press,et al. QSPR with TAU Indices: Water Solubility of Diverse Functional Acyclic Compounds # , 2003 .
[27] Roberto Todeschini,et al. Defining a novel k-nearest neighbours approach to assess the applicability domain of a QSAR model for reliable predictions , 2013, Journal of Cheminformatics.
[28] Risto O. Juvonen,et al. Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes , 2015, Front. Pharmacol..
[29] F. Gonzalez,et al. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. , 1994, Drug metabolism reviews.
[30] Francesca Grisoni,et al. Variable selection methods : an introduction , 2012 .
[31] R. Leardi,et al. Genetic algorithms applied to feature selection in PLS regression: how and when to use them , 1998 .
[32] D A Smith,et al. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics , 1996, Medicinal research reviews.
[33] C. Beedham. The role of non—P450 enzymes in drug oxidation. , 1997, Pharmacy World and Science.
[34] T. R. Brodribb,et al. Phenytoin and Fluorouracil Interaction , 2001, The Annals of pharmacotherapy.
[35] Roberto Todeschini,et al. Molecular descriptors for chemoinformatics , 2009 .
[36] E. Frei,et al. The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. , 2001, Biochemical pharmacology.
[37] B. Kowalski,et al. K-Nearest Neighbor Classification Rule (pattern recognition) applied to nuclear magnetic resonance spectral interpretation , 1972 .
[38] Ian T. Jolliffe,et al. Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.
[39] Khadija Iqbal,et al. An introduction , 1996, Neurobiology of Aging.
[40] R. Geary,et al. The Contiguity Ratio and Statistical Mapping , 1954 .
[41] R. Venkataraghavan,et al. Atom pairs as molecular features in structure-activity studies: definition and applications , 1985, J. Chem. Inf. Comput. Sci..
[42] Ruili Huang,et al. CERAPP: Collaborative Estrogen Receptor Activity Prediction Project , 2016, Environmental health perspectives.
[43] F. Gonzalez,et al. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. , 2005, Mutation research.
[44] W. Pryor. Cytochrome P450: Structure, mechanism, and biochemistry , 1996 .
[45] Anthony Long,et al. Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.
[46] F. Guengerich. Mechanisms of cytochrome P450 substrate oxidation: MiniReview , 2007, Journal of biochemical and molecular toxicology.
[47] Ernst Mutschler,et al. Drug actions : basic principles and theraputic aspects , 1995 .
[48] H. Mei,et al. An improved large-scale prediction model of CYP1A2 inhibitors by using combined fragment descriptors , 2015 .
[49] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[50] S. Wold,et al. Partial least squares analysis with cross‐validation for the two‐class problem: A Monte Carlo study , 1987 .
[51] M Cassotti,et al. Validation and extension of a similarity-based approach for prediction of acute aquatic toxicity towards Daphnia magna , 2014, SAR and QSAR in environmental research.
[52] Berith F. Jensen,et al. In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors. , 2007, Journal of medicinal chemistry.
[53] Stewart B Kirton,et al. Comparative modelling of cytochromes P450. , 2002, Advanced drug delivery reviews.
[54] Heng Tao Shen,et al. Principal Component Analysis , 2009, Encyclopedia of Biometrics.
[55] David E. Goldberg,et al. Genetic algorithms and Machine Learning , 1988, Machine Learning.
[56] Ram Vinay Pandey,et al. Novel advances in cytochrome P450 research. , 2011, Drug discovery today.
[57] Sason Shaik,et al. Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. , 2004, Chemical reviews.
[58] Ruili Huang,et al. Predictive Models for Cytochrome P450 Isozymes Based on Quantitative High Throughput Screening Data , 2011, J. Chem. Inf. Model..
[59] Maurizio Vichi,et al. Studies in Classification Data Analysis and knowledge Organization , 2011 .
[60] Thorsten Meinl,et al. KNIME: The Konstanz Information Miner , 2007, GfKl.
[61] U. Yasar,et al. Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients. , 2006, Basic & clinical pharmacology & toxicology.
[62] Maurice Dickins,et al. Compound lipophilicity for substrate binding to human P450s in drug metabolism. , 2004, Drug discovery today.
[63] Roberto Todeschini,et al. New Spectral Indices for Molecule Description , 2008 .
[64] Ruili Huang,et al. ehp CERAPP : Collaborative Estrogen Receptor Activity Prediction Project , 2016 .
[65] Emilio Benfenati,et al. Integration of QSAR models for bioconcentration suitable for REACH. , 2013, The Science of the total environment.
[66] Theofanis Sapatinas,et al. Discriminant Analysis and Statistical Pattern Recognition , 2005 .
[67] S Udenfriend,et al. Hydroxylation-induced migration: the NIH shift. Recent experiments reveal an unexpected and general result of enzymatic hydroxylation of aromatic compounds. , 1967, Science.